Thorne Quercetin Phytosome
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Evidence note: SASP biology is context-dependent. A marker change does not prove senescent-cell clearance or a clinical benefit.
The SASP is a complex secretory program involving hundreds of factors including inflammatory cytokines, chemokines, growth factors, proteases, and extracellular vesicles. SASP is driven primarily by NF-κB and C/EBPβ transcription factors activated by persistent DNA damage signaling. SASP can spread senescence to neighboring cells ("paracrine senescence"), drive cancer progression, and create a chronic inflammatory state that accelerates nearly every age-related disease.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Is SASP always inflammatory?
SASP composition varies by cell type and senescence inducer. Wound healing SASP is temporarily beneficial (promoting tissue repair via PDGF-AA, VEGF). Age-related, chronic SASP is persistently harmful. The distinction is between transient, targeted SASP vs persistent, systemic SASP from accumulated senescent cells.
Can diet alone reduce SASP?
Anti-inflammatory diets (Mediterranean, high polyphenol) reduce SASP-related markers in clinical studies. However, dietary polyphenol concentrations (quercetin, fisetin, curcumin from food) are far below senolytic threshold — diet reduces SASP expression but cannot eliminate the senescent cells producing it.
The senescence-associated secretory phenotype (SASP) describes molecules that some senescent cells release, including cytokines, chemokines, growth factors, and proteases. Its composition varies by cell type, trigger, tissue, and time. Interleukin-6 and other inflammatory signals are often studied, but no single marker proves that a person has a harmful senescent-cell burden.
The SASP can have useful short-term roles. After tissue injury, senescence-related signals may recruit immune cells and help coordinate repair; in other contexts, persistent signaling may contribute to chronic inflammation or alter nearby cells. This context dependence matters: broadly suppressing all SASP activity could interfere with normal repair, while a laboratory reduction in one cytokine does not show that disease risk has fallen.
Researchers use combinations of markers in blood, tissue, or experimental models, but there is no accepted clinical panel that measures total senescent-cell burden or guides supplement dosing. Blood markers are influenced by infections, obesity, smoking, medication, and many other conditions. A change after a supplement should not be interpreted as proof that senescent cells were removed.
People should not use commercial “senescence tests” to self-prescribe a senolytic cycle. For persistent inflammation or symptoms, seek a clinical evaluation for established causes. Lifestyle measures that support health—exercise, sleep, and treatment of chronic disease—have stronger practical justification than attempting to manipulate a single pathway.
FAQ
Is SASP the same in every tissue? No; it varies by cell and biological context.
Can a blood test show my SASP level? No standardized clinical test can quantify an individual’s harmful senescent-cell burden.
For intervention evidence, read the senolytics clinical-trials guide and fisetin safety profile.
Research: Foundational review of senescence-associated secretory phenotypes; NIA workshop on senescence-targeting clinical research.
8 mg fisetin per capsule
Low-dose fisetin with fenugreek galactomannans.
Best for: reviewing a low-dose fisetin label in What can be measured in people
View on Amazon · Affiliate link